Related Experiment Video
Updated: Aug 2, 2026
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Infantile hydrocephalus: long-term results of surgical therapy
Insights
This study on pediatric hydrocephalus treatment found that long-term survival rates are high, with most survivors achieving normal intelligence. Shunt infection risks were manageable, indicating effective surgical outcomes for children with hydrocephalus.
Area of Science:
- Pediatric Neurosurgery
- Neurology
- Medical device outcomes
Background:
- Hydrocephalus is a common neurological condition in children requiring surgical intervention.
- Ventriculoperitoneal shunts are a primary treatment modality for pediatric hydrocephalus.
- Long-term outcomes and complication rates are critical for evaluating treatment efficacy.
Purpose of the Study:
- To analyze the long-term results of surgical treatment for hydrocephalus in a pediatric cohort.
- To evaluate survival rates, cognitive outcomes, and shunt-related complications.
- To identify factors influencing treatment success in pediatric hydrocephalus.
Main Methods:
- Retrospective analysis of 170 children undergoing 636 operative procedures for hydrocephalus.
- Long-term follow-up ranging from 5 to 12 years.
- Assessment of survival, intelligence, and shunt infection rates.
Main Results:
- 5-year survival rate was 83.5%, with a current survival rate of 78.8%.
- Normal intelligence observed in 63.4% of 5-year survivors and 64.2% of current survivors.
- Procedural risk for early shunt infection was 5.8%, and late infection occurred in 6.5% of patients.
Conclusions:
- Surgical management of pediatric hydrocephalus yields favorable long-term survival and cognitive outcomes.
- Shunt infection represents a significant but manageable complication.
- Cerebral mantle thickness did not correlate with treatment outcomes.
Abstract:
A personal series of 170 children who underwent 636 operative procedures for hydrocephalus have been followed for 5-12 years. The results of treatment have been analyzed by etiology, years of follow-up, and summarized generally. 5-year survival was 83.5%, current survival is 78.8%. Normal intelligence was found in 63.4% of 5-year survivors, in 64.2% of current survivors. The procedural risk for early shunt infection was 5.8%, while 6.5% of the patients developed a late infection. There is no difference in results based upon measurement of the initial thickness of the cerebral mantle. The mean of the cumulative shunt procedures per patient is 3.72 +/- (SEM) 0.37, and for 5-year survivors it is 3.85 +/- (SEM) 0.39.
